ARCHIMED
Alice Morillon is an experienced operating partner specializing in sustainability, ESG, and impact investment, currently overseeing ArchiMed's Responsible Investment Strategy since January 2022. As a director at the EURÊKA Foundation and previously an impact director at ArchiMed, Alice has focused on advancing sustainable global healthcare through impactful investing. Prior roles include working with PwC to integrate ESG into investment analysis for various private equity firms, developing Environmental and Social Management Systems for Delta Capital Myanmar, and founding Hakha Textiles to support women refugees in Myanmar. Alice's diverse background combines legal expertise with a strong commitment to social impact, reflected in earlier positions with companies such as Veolia and ActionAid. Alice's educational credentials include advanced studies in law from institutions such as Columbia Law School and Sciences Po.
This person is not in any teams
This person is not in any offices
ARCHIMED
1 followers
With offices in Europe, North America and APAC, ARCHIMED is a leading investment firm focused exclusively on healthcare industries. Its mix of operational, medical, scientific and financial expertise allows ARCHIMED to serve as both a strategic and financial partner to healthcare businesses. Prioritized areas of focus include Biopharma Products, Consumer Health, Healthcare IT, In Vitro Diagnostics, Life Science Tools & Biologic Services, MedTech, and Pharma Services. ARCHIMED helps partners internationalize, acquire, innovate and expand their products and services. ARCHIMED manages €7 billion across its various funds, including the largest healthcare-only private equity fund raised by a European-based General Partner. Since inception, ARCHIMED has been a committed Impact investor, both directly and through its EURÊKA Foundation.